Who Buys Imipenem from India — 302 Importers Behind a $33.3M Market
India's imipenem import market is served by 302 active buyers who collectively imported $33.3M across 803 shipments. LABORATORIOS JAYOR S.A. DE C.V. (MEXICO) leads with a 10.8% market share, followed by YUSEN LOGISTICS BENELUX BELGIUM and LABORATORIOS JAYOR S A DE C V. The top 5 buyers together control 31.0% of total import value, reflecting a moderately competitive buyer landscape.
Imipenem buyer data — 302 importers · $33.3M market · 803 shipmentsTransData Nexus · Indian Customs Data
Top Imipenem Importers — Ranked by Import Value
LABORATORIOS JAYOR S.A. DE C.V. (MEXICO) is the leading imipenem importer from India, holding a 10.8% share of the $33.3M market across 803 shipments from 302 buyers. The top 5 buyers — LABORATORIOS JAYOR S.A. DE C.V. (MEXICO), YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), LABORATORIOS JAYOR S A DE C V (MEXICO), M/S. SUN PHARMACEUTICALS MOROCCO LL (MOROCCO), PHARMEDIC SA (ECUADOR) — collectively control 31.0% of total import value.
Top Imipenem Buyers & Importers
Ranked by import value · 302 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Imipenem Buyers & Importers — Ranked by Import Value. 302 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Imipenem — and from which countries?
Flow of Imipenem exports from India: each country's share and the named importers behind the numbers
Imipenem — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 58.0% of global Imipenem imports — led by Mexico (27.2%) with a total trade value of $33.3M across 803 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Mexico
Mexico emerges as the first largest importing country, achieving a total trade value of $9.1M through 20 shipments. This represents a market share of 27.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Mexico has a diverse importer base, with their top importers including:
• LABORATORIOS JAYOR S.A. DE C.V. - $3.6M (39.6% of country's total business)
• LABORATORIOS JAYOR S A DE C V - $1.8M (20.2% of country's total business)
• L J S.A DE CV - $1.1M (12.0% of country's total business)
• L J S A D C - $944.6K (10.4% of country's total business)
• LABORATORIOS JAYOR, S. A. DE C. V - $772.6K (8.5% of country's total business)
• Rest of Mexico's importers - $847.9K (9.3% of country's total business)
Key Insight: Mexico demonstrates strong market positioning with an average shipment value of $453.4K, indicating premium pricing strategy compared to the market average of $41.5K.
Mexico is a key market for Imipenem imports, representing 27.2% of total trade value.
The importation of Imipenem from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like Yusen Logistics Benelux Belgium (Belgium, $2.21M) and Pharmedic SA (Ecuador, $1.29M) function as intermediaries, procuring large quantities to supply regional markets. Their purchasing patterns are characterized by bulk orders to meet the demands of multiple clients.
Hospital Groups: Organizations such as M/S. Sun Pharmaceuticals Morocco LL (Morocco, $1.41M) and Bank of Ceylon (Sri Lanka, $1.17M) represent healthcare institutions acquiring Imipenem for direct patient care. Their procurement is typically based on anticipated patient needs and treatment protocols, leading to regular, sizable orders.
Government Procurement Agencies: Entities like Bank of Ceylon (Sri Lanka, $1.17M) often engage in tender-based purchasing to supply public healthcare facilities. Their buying behavior is influenced by national health policies and budget allocations, resulting in periodic, large-scale procurements.
Re-exporters: Companies such as Yusen Logistics Benelux Belgium Keetberglaan (Belgium, $0.83M) may purchase Imipenem for redistribution to other markets. Their order patterns are driven by global demand fluctuations and trade agreements, leading to variable purchasing volumes.
1Regulatory Authority: Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).
2Import Registration Process: Importers must obtain a Sanitary Registration, involving submission of product dossiers, quality control documentation, and compliance with Good Manufacturing Practices (GMP).
3Estimated Timeline: Approximately 6-12 months, depending on dossier completeness and regulatory workload.
4Import Tariff/Duty: For HS Code 30049099, the import duty is typically 0%, but importers should verify current rates with Mexican customs authorities.
Belgium:
1Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
The demand for Imipenem in importing countries is driven by several factors:
Disease Prevalence: Imipenem is a broad-spectrum antibiotic used to treat severe bacterial infections, including those caused by multidrug-resistant organisms. The rising incidence of such infections globally has increased the need for effective treatments.
Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of antibiotics like Imipenem. For instance, national action plans focusing on antimicrobial stewardship have been established in various regions.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to improved access to essential medicines. Countries expanding their healthcare infrastructure and coverage are likely to increase imports of critical antibiotics.
WHO Essential Medicines List Procurement: Imipenem is included in the WHO Model List of Essential Medicines, guiding countries in prioritizing procurement to ensure availability in public health systems.
Common Questions — Imipenem Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest imipenem buyer importing from India?
Based on import volume and value, LABORATORIOS JAYOR S.A. DE C.V. (MEXICO) leads with $3.6M in imports and a 10.8% market share — the highest of any single imipenem importer. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and LABORATORIOS JAYOR S A DE C V (MEXICO) are the next largest buyers.
QHow many companies buy imipenem from India?
There are 302 active imipenem buyers importing from India, with a combined market of $33.3M across 803 shipments to 94 countries. The top 5 buyers hold 31.0% of total import value, while the remaining 297 buyers handle the other 69.0%.
QWhich countries import the most imipenem from India?
The top importing countries for imipenem from India are Mexico (27.2%), Belgium (10.0%), Sri Lanka (7.4%), Morocco (7.4%), Myanmar (6.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of imipenem, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for imipenem from India?
The average import transaction value for imipenem from India is $41.5K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Imipenem from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like Yusen Logistics Benelux Belgium (Belgium, $2.21M) and Pharmedic SA (Ecuador, $1.29M) function as intermediaries, procuring large quantities to supply regional markets. Their purchasing patterns are characterized by bulk orders to meet the demands of multiple clients.
Hospital Groups: Organizations such as M/S. Sun Pharmaceuticals Morocco LL (Morocco, $1.41M) and Bank of Ceylon (Sri Lanka, $1.17M) represent healthcare institutions acquiring Imipenem for direct patient care. Their procurement is typically based on anticipated patient needs and treatment protocols, leading to regular, sizable orders.
Government Procurement Agencies: Entities like Bank of Ceylon (Sri Lanka, $1.17M) often engage in tender-based purchasing to supply public healthcare facilities. Their buying behavior is influenced by national health policies and budget allocations, resulting in periodic, large-scale procurements.
Re-exporters: Companies such as Yusen Logistics Benelux Belgium Keetberglaan (Belgium, $0.83M) may purchase Imipenem for redistribution to other markets. Their order patterns are driven by global demand fluctuations and trade agreements, leading to variable purchasing volumes.
1Regulatory Authority: Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).
2Import Registration Process: Importers must obtain a Sanitary Registration, involving submission of product dossiers, quality control documentation, and compliance with Good Manufacturing Practices (GMP).
3Estimated Timeline: Approximately 6-12 months, depending on dossier completeness and regulatory workload.
4Import Tariff/Duty: For HS Code 30049099, the import duty is typically 0%, but importers should verify current rates with Mexican customs authorities.
Belgium:
1Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
The demand for Imipenem in importing countries is driven by several factors:
Disease Prevalence: Imipenem is a broad-spectrum antibiotic used to treat severe bacterial infections, including those caused by multidrug-resistant organisms. The rising incidence of such infections globally has increased the need for effective treatments.
Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of antibiotics like Imipenem. For instance, national action plans focusing on antimicrobial stewardship have been established in various regions.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to improved access to essential medicines. Countries expanding their healthcare infrastructure and coverage are likely to increase imports of critical antibiotics.
WHO Essential Medicines List Procurement: Imipenem is included in the WHO Model List of Essential Medicines, guiding countries in prioritizing procurement to ensure availability in public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $3.3M through 38 shipments. This represents a market share of 10.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $2.2M (66.0% of country's total business)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN - $831.1K (24.8% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $88.0K, indicating premium pricing strategy compared to the market average of $41.5K.
Belgium is a key market for Imipenem imports, representing 10.0% of total trade value.
Primary Market
Secondary Market
3Sri Lanka
Sri Lanka emerges as the third largest importing country, achieving a total trade value of $2.5M through 2 shipments. This represents a market share of 7.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• BANK OF CEYLON - $1.2M (47.4% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $1.2M, indicating premium pricing strategy compared to the market average of $41.5K.
Sri Lanka is a key market for Imipenem imports, representing 7.4% of total trade value.
Primary Market
Secondary Market
4Morocco
Morocco emerges as the fourth largest importing country, achieving a total trade value of $2.5M through 17 shipments. This represents a market share of 7.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Morocco has a diverse importer base, with their top importers including:
• M/S. SUN PHARMACEUTICALS MOROCCO LL - $1.4M (57.3% of country's total business)
• MS SUN PHARMACEUTICALS MOROCCO LL - $548.3K (22.3% of country's total business)
Key Insight: Morocco demonstrates strong market positioning with an average shipment value of $144.6K, indicating premium pricing strategy compared to the market average of $41.5K.
Morocco is a key market for Imipenem imports, representing 7.4% of total trade value.
Primary Market
Secondary Market
5Myanmar
Myanmar emerges as the fifth largest importing country, achieving a total trade value of $2.0M through 4 shipments. This represents a market share of 6.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Myanmar has a diverse importer base, with their top importers including:
• LIFELINE CO LIMITED - $582.8K (29.0% of country's total business)
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $502.6K, indicating premium pricing strategy compared to the market average of $41.5K.
Myanmar is a key market for Imipenem imports, representing 6.0% of total trade value.
Primary Market
Secondary Market
Contract Manufacturers: Firms like L J S.A de CV (Mexico, $1.09M) and L J S A D C (Mexico, $0.94M) might procure Imipenem as an active pharmaceutical ingredient for formulation into finished products. Their procurement is aligned with production schedules and client contracts, resulting in consistent, moderate-sized orders.
TransData Nexus Research · Government and regulatory sourcesMar 2026
2Import Registration Process: Requires a Marketing Authorization (MA), necessitating submission of a Common Technical Document (CTD), including clinical data and GMP certification.
3Estimated Timeline: Approximately 7-12 months, subject to the evaluation process and any additional information requests.
4Import Tariff/Duty: As an EU member, Belgium applies a 0% import duty on pharmaceutical products under HS Code 30049099.
Sri Lanka:
1Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2Import Registration Process: Involves obtaining a Registration Certificate by submitting product dossiers, including quality, safety, and efficacy data, along with GMP compliance.
3Estimated Timeline: Approximately 6-9 months, depending on the review process and any required clarifications.
4Import Tariff/Duty: Import duties for HS Code 30049099 are generally low, often around 0-5%, but importers should confirm current rates with Sri Lankan customs.
Morocco:
1Regulatory Authority: Direction du Médicament et de la Pharmacie (DMP).
2Import Registration Process: Requires a Marketing Authorization, involving submission of a comprehensive dossier detailing product quality, safety, efficacy, and GMP certification.
3Estimated Timeline: Approximately 8-12 months, subject to the completeness of the application and regulatory review.
4Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 typically attract an import duty of around 2.5%, but rates should be verified with Moroccan customs authorities.
Myanmar:
1Regulatory Authority: Food and Drug Administration (FDA) Myanmar.
2Import Registration Process: Importers must obtain a Product Registration Certificate by submitting detailed dossiers, including quality control data, clinical studies, and GMP compliance.
3Estimated Timeline: Approximately 9-12 months, depending on the thoroughness of the submission and regulatory workload.
4Import Tariff/Duty: Import duties for HS Code 30049099 are generally low, often around 0-5%, but importers should confirm current rates with Myanmar customs.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare providers utilize tender systems to procure medicines, ensuring cost-effectiveness and consistent supply. This approach often results in bulk purchasing of essential antibiotics like Imipenem.
With 302 buyers across 94 countries, the global market for Imipenem presents significant opportunities. The combination of increasing antimicrobial resistance, governmental health initiatives, and structured procurement processes underscores the sustained demand for this antibiotic.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$4.71 per unit
Contract Manufacturers: Firms like L J S.A de CV (Mexico, $1.09M) and L J S A D C (Mexico, $0.94M) might procure Imipenem as an active pharmaceutical ingredient for formulation into finished products. Their procurement is aligned with production schedules and client contracts, resulting in consistent, moderate-sized orders.
TransData Nexus Research · Government and regulatory sourcesMar 2026
2Import Registration Process: Requires a Marketing Authorization (MA), necessitating submission of a Common Technical Document (CTD), including clinical data and GMP certification.
3Estimated Timeline: Approximately 7-12 months, subject to the evaluation process and any additional information requests.
4Import Tariff/Duty: As an EU member, Belgium applies a 0% import duty on pharmaceutical products under HS Code 30049099.
Sri Lanka:
1Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2Import Registration Process: Involves obtaining a Registration Certificate by submitting product dossiers, including quality, safety, and efficacy data, along with GMP compliance.
3Estimated Timeline: Approximately 6-9 months, depending on the review process and any required clarifications.
4Import Tariff/Duty: Import duties for HS Code 30049099 are generally low, often around 0-5%, but importers should confirm current rates with Sri Lankan customs.
Morocco:
1Regulatory Authority: Direction du Médicament et de la Pharmacie (DMP).
2Import Registration Process: Requires a Marketing Authorization, involving submission of a comprehensive dossier detailing product quality, safety, efficacy, and GMP certification.
3Estimated Timeline: Approximately 8-12 months, subject to the completeness of the application and regulatory review.
4Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 typically attract an import duty of around 2.5%, but rates should be verified with Moroccan customs authorities.
Myanmar:
1Regulatory Authority: Food and Drug Administration (FDA) Myanmar.
2Import Registration Process: Importers must obtain a Product Registration Certificate by submitting detailed dossiers, including quality control data, clinical studies, and GMP compliance.
3Estimated Timeline: Approximately 9-12 months, depending on the thoroughness of the submission and regulatory workload.
4Import Tariff/Duty: Import duties for HS Code 30049099 are generally low, often around 0-5%, but importers should confirm current rates with Myanmar customs.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare providers utilize tender systems to procure medicines, ensuring cost-effectiveness and consistent supply. This approach often results in bulk purchasing of essential antibiotics like Imipenem.
With 302 buyers across 94 countries, the global market for Imipenem presents significant opportunities. The combination of increasing antimicrobial resistance, governmental health initiatives, and structured procurement processes underscores the sustained demand for this antibiotic.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 302 global importers of Imipenem identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 803 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 94 destination countries with market share per buyer calculated from capped values.
